Insulin Clinics / Foundations

How insulin is delivered

Insulin can be given by syringe, pen, pump, or inhaler. Each has trade-offs in cost, convenience, precision, and the kind of life it fits into.

Medically reviewed by [Name, MD] · Last reviewed: [Month YYYY]

Vials and syringes

The original delivery method, and still the cheapest. Insulin comes in a glass vial (usually 10 mL of U-100) and is drawn into a single-use syringe before each injection. Syringes come in different sizes — 0.3 mL (up to 30 units), 0.5 mL (up to 50 units), and 1 mL (up to 100 units) — with 4, 5, 6, or 8 mm needles attached.

Pros

• Lowest cost per dose by a wide margin, especially with older insulins.
• Easy to mix two insulins in one syringe (for example, NPH and regular).
• Available almost anywhere; ReliOn syringes are sold over the counter.

Cons

• More steps before each dose, more room for error.
• Drawing tiny doses (less than 5 units) is harder to do accurately.
• Less discreet in public.

Disposable insulin pens

A disposable pen is a single device pre-filled with insulin (usually 300 units, sometimes 600). You attach a fresh pen needle, dial the dose, inject, and remove the needle. When the pen is empty, the whole device is thrown away. Most modern insulins come in this form.

Pros

• Faster than vials and syringes; fewer steps.
• Dose dial is easier to read and more accurate, especially for small doses or vision problems.
• More portable and discreet.
• "Memory" pens (some Novo Nordisk and Lilly products) record the time and amount of the last dose.

Cons

• Higher cost than vials, especially in the U.S.
• You cannot mix two insulins in one device.
• Pen needles are an additional supply that may be billed separately.

Reusable pens with cartridges

Reusable pens are durable devices (metal or plastic) that take a replaceable cartridge of insulin. They are common outside the U.S. and used by some U.S. patients. The pen lasts for years; only the 3 mL cartridges and pen needles get replaced. Reusable pens generate less plastic waste and can be slightly cheaper over time, depending on the cartridge price.

Insulin pumps

An insulin pump is a small device that delivers rapid-acting insulin continuously through a thin tube and a cannula (a soft plastic tube under the skin), or directly through a patch. The user — or in newer systems, the algorithm — also instructs the pump to deliver bolus doses for meals and corrections.

Tubed pumps

A tubed pump (Tandem t:slim X2, Medtronic 780G, others) is worn clipped to a belt or in a pocket. Thin tubing connects it to an infusion set placed on the abdomen, thigh, or another fatty area. The infusion set is changed every 2–3 days; the pump itself lasts 4 years or more.

Patch pumps

A patch pump (Omnipod 5, Twiist) sticks directly to the skin. There is no tubing; the pump and infusion site are one unit, controlled wirelessly from a phone or controller. Each "pod" lasts about 3 days, then is removed and a new one is placed.

Hybrid closed-loop systems

The most important shift in insulin delivery in the last decade is the hybrid closed-loop system, sometimes called an "artificial pancreas." A continuous glucose monitor (CGM) talks to the pump, and an algorithm adjusts basal insulin every few minutes based on glucose trends. The user still announces meals and confirms boluses — that is the "hybrid" part — but overnight basal regulation is largely automatic.

Studies and real-world data show these systems consistently increase time in the target glucose range and reduce overnight lows compared with manual pumps or injections in type 1 diabetes. They are also approved for type 2 diabetes in some cases. Examples include the Tandem t:slim X2 with Control-IQ, Medtronic MiniMed 780G, Omnipod 5, and the Twiist system. The iLet Bionic Pancreas takes a simpler approach where the user enters meal size as small/usual/large rather than counting carbs.

Pros and cons of pump therapy

Pumps offer fine-grained control (basal rates can vary by hour, doses can be 0.025 units in some pumps) and remove the need for multiple daily injections. Closed-loop pumps add automated correction overnight and during exercise, which is where most people get into trouble.

The trade-offs: pumps are expensive (the device, the supplies, the CGM), they require training to use safely, an infusion set failure can cause rapid hyperglycemia and DKA because there is no long-acting insulin in the body, and many people simply do not want a device attached to them.

Inhaled insulin

Inhaled insulin (Afrezza) is a fine powder of regular human insulin breathed in through a small reusable inhaler at the start of a meal. It absorbs through the lungs, starts working within minutes, and is gone within about 2–3 hours.

It is approved as a mealtime insulin only — it does not replace basal insulin. It comes in 4-, 8-, and 12-unit cartridges, which makes very fine dose adjustments harder. It is not appropriate for people with asthma, COPD, or other chronic lung disease, and the FDA requires lung function testing before starting and periodically thereafter. Some people who dislike injections find it valuable; others find the cost or the dose granularity limiting.

Cost considerations

Across all of these methods, cost varies dramatically by insurance, geography, and the specific product. As a rough ordering in the U.S.:

• Lowest: regular and NPH insulin in vials with syringes (ReliOn at Walmart, often under $30 per vial).
• Moderate: analog insulin in vials; some biosimilar pens.
• Higher: brand-name analog pens; pump supplies; CGM sensors.
• Highest: hybrid closed-loop systems including pump, supplies, and CGM together.

The cost and access page covers patient assistance programs, the $35 Medicare cap, and what to do when you cannot afford this month's supply.

Who tends to use what

There is no single right answer. Some patterns are common:

• People newly starting insulin in type 2 diabetes most often begin with a pen for once-daily basal insulin.
• Pediatric type 1 diabetes care has shifted heavily toward CGMs and pumps, especially closed-loop systems.
• Adults with type 1 diabetes split roughly between multiple daily injections (with a CGM) and pumps; both can produce excellent results.
• People with limited insurance, or who travel to places where supplies are uncertain, often choose injection-based regimens for resilience.
• People with very small total daily doses (some children, some adults with high insulin sensitivity) benefit from pumps that deliver in fractions of a unit.

The right delivery method is the one you will actually use reliably, that you can afford, and that your care team can support. It is reasonable — and common — to switch over time as needs and circumstances change.